Project Management in Drug Development

We offer full service in Drug Development from API, over its pharmaceutical formulation, the non-clinical development including primary and secondary pharmacodynamics, safety, pharmacokinetics, toxicology, and clinical development from phase I to phase IV. This includes relatively straightforward low-complexity projects (certain aspects of chemical, pharmaceutical, preclinical or clinical development) as well as the overall management of complex drug development projects for new chemical entities or biosimilars. By making use of CDRD AB services, the client can take advantage of the company’s expertise and its well rehearsed team and process platforms, resulting in maximum efficacy and reliability. Furthermore, the client gets access to CDRD AB network within and outside the BDD/CDRD Group, including excellent relations to opinion leaders, regulatory authorities as well as validated contract manufacturers and contract research organisations. CDRDAB is flexible to offer services tailored to our customers needs.